The University of Chicago Header Logo

Connection

David Rubin to Hematologic Diseases

Back to Details
This is a "connection" page, showing publications David Rubin has written about Hematologic Diseases.
David Rubin
Connection Strength
0.350
Hematologic Diseases
  1. Effect of adalimumab on clinical laboratory parameters in patients with Crohn's disease: results from the CHARM trial. Inflamm Bowel Dis. 2012 May; 18(5):818-25.
    View in: PubMed
    Score: 0.350
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.